the community site for and by
developmental and stem cell biologists

Developing news

Posted by , on 25 October 2022

This week, #SciTwitter has been focussed on discussions around publishing, starting with prestige-signalling, followed by a big announcement from eLife, which received mixed reactions on Twitter. Going forward, eLife will no longer be accept or reject papers after review, but will publish a version of record (VOR) alongside public peer reviews. Check out their announcement for more details. We’ve picked out some tweets on both topics, and as always, click on the tweet for the full discussion and the opportunity to fall into a Twitter rabbit hole!

Prestige-signalling

eLife announcement

Thumbs up (1 votes)
Loading...

Tags:
Categories: Discussion

Leave a Reply

Your email address will not be published. Required fields are marked *

Get involved

Create an account or log in to post your story on the Node.

Sign up for emails

Subscribe to our mailing lists.

Do you have any news to share?

Our ‘Developing news’ posts celebrate the various achievements of the people in the developmental and stem cell biology community. Let us know if you would like to share some news.